| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Immunic, Inc. (IMUX) has 12 insiders with recent SEC Form 4 filings, including 9 buys and 0 sells. IMUX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.72M | $20.00M | - | |
| CFO | 560.0K | $6.51M | - | |
| Other | 330.0K | $3.84M | - | |
| COO | 330.0K | $3.84M | - | |
| Other | 315.0K | $3.66M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 12, 2016 | Hasnain Faheem74 | Director | Buy | 118,243 | $5.92 | $699,998.56 | +2,628% | |
| Oct 28, 2015 | Satter Muneer A58 | Director, 10% Owner | Buy | 400,000 | $5.50 | $2,200,000.00 | +5.9% | |
| Oct 26, 2015 | Cohen Cheryl77 | Director | Buy | 3,500 | $7.17 | $25,089.75 | New | |
| Oct 26, 2015 | Dunn John Michael | General Counsel And Secretary | Buy | 9,385 | $6.81 | $63,932.94 | +127.1% | |
| Sep 10, 2015 | Bienaime Jean Jacques68 | Director | Buy | 14,000 | $3.08 | $43,093.40 | +11.8% |